Within the coming years, Mr. Eterginio intends to rise to a role as a National Sales Director and lead a managed markets division.
SOUTHINGTON, CT, July 14, 2023 /24-7PressRelease/ -- Barry C. Eterginio has been included in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.
An ethical and genuine professional who has dedicated his stellar career to extending the lives of people diagnosed with cancer, Mr. Eterginio has earned distinction as an Oncology National Account Manager for Biocon Biologics. As one of only eight individuals in the country who has this position, since 2022 he has focused his efforts on collaborating with C-suite and D-suite leaders while managing his clients' books of business. He also presents contract proposals to internal teams, determining the business case rationale and market impact of their decisions.
Prior to his current role, Mr. Eterginio began his career as a Medical Equipment Representative for Abbott in 1995 and became the District Manager in the cardiovascular franchise for Bristol-Myers Squibb in 1997. Following this time, he served as a Critical Care Specialist for Eli Lilly and Company in 2001 and was promoted to an Executive Acute Care Specialist in 2002 and to an Executive Oncology Specialist in 2004. He continued his career as a Senior Institution Academic Oncology Specialist for Johnson & Johnson in 2006. He subsequently joined Novartis as an Executive Oncology Sales Specialist in 2008, earning a promotion to a Senior Rare Disease Specialist with oncology and rare disease franchise in 2011.
Following this period, Mr. Eterginio was a Corporate Account Manager for Dendreon in 2013 and became an Oncology Key Account Manager for Sandoz in 2016. Later that year, he was promoted to an Oncology Regional Account Manager and then to a Commercial Business Manager in 2019. Over the course of his career, he was honored with 13 President's Club Awards for his stellar work.
To prepare for his professional journey, Mr. Eterginio earned a Bachelor of Science in Marketing and Finance from Bentley University in 1993. Following this achievement, he attained a Master of Business Administration from Quinnipiac University in 1996 and completed a postgraduate course and certification in Healthcare Compliance in 2010. Well-qualified in his field, he has completed numerous LinkedIn courses in time management, productivity and other managerial areas as well as seminars and continuing education courses.
Within the coming years, Mr. Eterginio intends to rise to a role as a National Sales Director and lead a managed markets division, which is comprised of national account managers, key account managers, GPO and peer personnel. He is proud to have launched the first oncology biosimilar in the marketplace and is driven by a strong work ethic and a dedication to compliance, ensuring patients with cancer have the ability to extend and improve their lives.
About Marquis Who's Who®:
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Marquis celebrates its 125th anniversary in 2023, and Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. Marquis® publications may be visited at the official Marquis Who's Who® website at www.marquiswhoswho.com.
# # #